INVO Fertility Inc (IVF)

Form 8-K - Current report

Form DEF 14A - Other definitive proxy statements

Form 8-K - Current report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

INVO Fertility Reports First Quarter 2026 Results Reflecting Strong Revenue Growth, Expanded Fertility Clinic Platform, and Improved Capital Structure

23% revenue growth, elimination of all Series C-2 Preferred Stock and warrant liabilities, and a strengthened...

Form 8-K - Current report

Form PRE 14A - Other preliminary proxy statements

Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]

INVO Fertility Receives Nasdaq Notification Regarding Late Filing of Quarterly Report on Form 10-Q

SARASOTA, Fla., June 02, 2026 (GLOBE NEWSWIRE) -- INVO Fertility, Inc. (Nasdaq: IVF) (“INVO” or the...

Form 8-K - Current report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]

Form 8-K - Current report

INVO Fertility Announces Fiscal Year 2025 Financial Results

SARASOTA, Fla., June 02, 2026 (GLOBE NEWSWIRE) -- INVO Fertility, Inc. (Nasdaq: IVF) (“INVO Fertility” or the...

Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]